Advertisement

Current Diabetes Reports

, 14:445 | Cite as

Inpatient Hypoglycemia: A Challenge That Must Be Addressed

  • Leslie Eiland
  • Whitney Goldner
  • Andjela Drincic
  • Cyrus DesouzaEmail author
Hospital Management of Diabetes (G Umpierrez, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Hospital Management of Diabetes

Abstract

Hypoglycemia in the inpatient setting is a common occurrence with potentially harmful outcomes. Large trials in both the inpatient and outpatient settings have found a correlation between hypoglycemia and morbidity and mortality. The incidence of hypoglycemia is difficult to assess, due to a lack of standardized definitions and different methods of data collection between hospital systems. Risk factors that predispose to hypoglycemia involve the changing clinical statuses of patients, nutrition issues, and hospital processes. Mechanisms contributing to morbidity due to hypoglycemia may include an increase in sympathoadrenal responses, as well as indirect changes affecting cytokine production, coagulation, fibrinolysis, and endothelial function. Prevention of hypoglycemia requires implementation of several strategies that include patient safety, quality control, multidisciplinary communication, and transitions of care. In this article, we discuss all of these issues and provide suggestions to help predict and prevent hypoglycemic episodes during an inpatient stay. We address the issues that occur upon admission, during the hospital stay, and around the time of discharge. We believe that decreasing the incidence of inpatient hypoglycemia will both decrease costs and improve patient outcomes.

Keywords

Inpatient Hypoglycemia Diabetes Complications Prevention Insulin 

Notes

Acknowledgments

The contents of this article do not reflect the views of the VA and are the opinion of the authors.

Compliance with Ethics Guidelines

Conflict of Interest

Leslie Eiland, Whitney Goldner, Andjela Drincic, and Cyrus Desouza declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Umpierrez GE, Hor T, Smiley D, Temponi A, Umpierrez D, Ceron M, et al. Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes. J Clin Endocrinol Metab. 2009;94:564–9. doi: 10.1210/jc.2008-1441.PubMedCrossRefGoogle Scholar
  2. 2.
    Turchin A, Matheny ME, Shubina M, Scanlon JV, Greenwood B, Pendergrass ML. Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward. Diabetes Care. 2009;32:1153–7. doi: 10.2337/dc08-2127.PubMedCrossRefGoogle Scholar
  3. 3.
    Elliott MB, Schafers SJ, McGill JB, Tobin GS. Prediction and prevention of treatment-related inpatient hypoglycemia. J Diabetes Sci Technol. 2012;6:302–9.PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560–72. doi: 10.1056/NEJMoa0802987.PubMedCrossRefGoogle Scholar
  5. 5.
    •• NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283–97. doi: 10.1056/NEJMoa0810625. This is an important trial that provided evidence that inpatient hypoglycemia may be detrimental.PubMedCrossRefGoogle Scholar
  6. 6.
    Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125–39. doi: 10.1056/NEJMoa070716.PubMedCrossRefGoogle Scholar
  7. 7.
    Preiser JC, Devos P, Ruiz-Santana S, Melot C, Annane D, Groeneveld J, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009;35:1738–48. doi: 10.1007/s00134-009-1585-2.PubMedCrossRefGoogle Scholar
  8. 8.
    • Umpierrez GE, Smiley D, Jacobs S, Peng L, Temponi A, Mulligan P, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care. 2011;34:256–61. doi: 10.2337/dc10-1407. This study shows the methods by which inpatients can be treated without undue hypoglycemia.PubMedCrossRefGoogle Scholar
  9. 9.
    Varghese P, Gleason V, Sorokin R, Senholzi C, Jabbour S, Gottlieb JE. Hypoglycemia in hospitalized patients treated with antihyperglycemic agents. J Hosp Med. 2007;2:234–40. doi: 10.1002/jhm.212.PubMedCrossRefGoogle Scholar
  10. 10.
    Cook CB, Kongable GL, Potter DJ, Abad VJ, Leija DE, Anderson M. Inpatient glucose control: a glycemic survey of 126 U.S. hospitals. J Hosp Med. 2009;4:E7–E14. doi: 10.1002/jhm.533.PubMedCrossRefGoogle Scholar
  11. 11.
    Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff Jr DC, Bigger JT, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545–59. doi: 10.1056/NEJMoa0802743.PubMedCrossRefGoogle Scholar
  12. 12.
    •• Workgroup on Hypoglycemia, American Diabetes Association. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care. 2005;28:1245–9. This is a useful guideline to what is defined as hypoglycemia and why and how it can be reported.CrossRefGoogle Scholar
  13. 13.
    Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract. 2009;15:353–69. doi: 10.4158/EP09102.RA.PubMedCrossRefGoogle Scholar
  14. 14.
    van der Crabben SN, Blumer RM, Stegenga ME, Ackermans MT, Endert E, Tanck MW, et al. Early endotoxemia increases peripheral and hepatic insulin sensitivity in healthy humans. J Clin Endocrinol Metab. 2009;94:463–8. doi: 10.1210/jc.2008-0761.PubMedCrossRefGoogle Scholar
  15. 15.
    Farrokhi F, Klindukhova O, Chandra P, Peng L, Smiley D, Newton C, et al. Risk factors for inpatient hypoglycemia during subcutaneous insulin therapy in non-critically ill patients with type 2 diabetes. J Diabetes Sci Technol. 2012;6:1022–9.PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Maynard G, Wesorick DH, O'Malley C, Inzucchi SE, Society of Hospital Medicine Glycemic Control Task Force. Subcutaneous insulin order sets and protocols: effective design and implementation strategies. J Hosp Med. 2008;3:29–41. doi: 10.1002/jhm.354.PubMedCrossRefGoogle Scholar
  17. 17.
    Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129–39. doi: 10.1056/NEJMoa0808431.PubMedCrossRefGoogle Scholar
  18. 18.
    • Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care. 2010;33:1389–94. doi: 10.2337/dc09-2082. Useful review of the CVD risk that might be associated with severe hypoglycemia and the mechanisms involved.PubMedCrossRefGoogle Scholar
  19. 19.
    Smith WD, Winterstein AG, Johns T, Rosenberg E, Sauer BC. Causes of hyperglycemia and hypoglycemia in adult inpatients. Am J Health Syst Pharm. 2005;62:714–9.PubMedGoogle Scholar
  20. 20.
    Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, Montori VM, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97:16–38. doi: 10.1210/jc.2011-2098.PubMedCrossRefGoogle Scholar
  21. 21.
    Hellman R. A systems approach to reducing errors in insulin therapy in the inpatient setting. Endocr Pract. 2004;10 Suppl 2:100–8.PubMedCrossRefGoogle Scholar
  22. 22.
    Hellman R. Patient safety and inpatient glycemic control: translating concepts into action. Endocr Pract. 2006;12 Suppl 3:49–55.PubMedCrossRefGoogle Scholar
  23. 23.
    Umpierrez GE, Palacio A, Smiley D. Sliding scale insulin use: myth or insanity? Am J Med. 2007;120:563–7. doi: 10.1016/j.amjmed.2006.05.070.PubMedCrossRefGoogle Scholar
  24. 24.
    Goldberg PA, Siegel MD, Sherwin RS, Halickman JI, Lee M, Bailey VA, et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care. 2004;27:461–7.PubMedCrossRefGoogle Scholar
  25. 25.
    Donihi AC, Raval D, Saul M, Korytkowski MT, DeVita MA. Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients. Endocr Pract. 2006;12:358–62.PubMedCrossRefGoogle Scholar
  26. 26.
    Noschese M, Donihi AC, Koerbel G, Karslioglu E, Dinardo M, Curll M, et al. Effect of a diabetes order set on glycaemic management and control in the hospital. Qual Saf Health Care. 2008;17:464–8. doi: 10.1136/qshc.2006.021790.PubMedCrossRefGoogle Scholar
  27. 27.
    Cohen MR, Proulx SM, Crawford SY. Survey of hospital systems and common serious medication errors. J Healthc Risk Manag. 1998;18:16–27. doi: 10.1002/jhrm.5600180104.PubMedCrossRefGoogle Scholar
  28. 28.
    Amori RE, Pittas AG, Siegel RD, Kumar S, Chen JS, Karnam S, et al. Inpatient medical errors involving glucose-lowering medications and their impact on patients: review of 2,598 incidents from a voluntary electronic error-reporting database. Endocr Pract. 2008;14:535–42.PubMedCrossRefGoogle Scholar
  29. 29.
    Kosiborod M, Inzucchi SE, Goyal A, Krumholz HM, Masoudi FA, Xiao L, et al. Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. JAMA. 2009;301:1556–64. doi: 10.1001/jama.2009.496.PubMedCrossRefGoogle Scholar
  30. 30.
    Boucai L, Southern WN, Zonszein J. Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities. Am J Med. 2011;124:1028–35. doi: 10.1016/j.amjmed.2011.07.011.PubMedCentralPubMedCrossRefGoogle Scholar
  31. 31.
    van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359–67. doi: 10.1056/NEJMoa011300.PubMedCrossRefGoogle Scholar
  32. 32.
    Schwartz NS, Clutter WE, Shah SD, Cryer PE. Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. J Clin Invest. 1987;79:777–81. doi: 10.1172/JCI112884.PubMedCentralPubMedCrossRefGoogle Scholar
  33. 33.
    Mitrakou A, Ryan C, Veneman T, Mokan M, Jenssen T, Kiss I, et al. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol. 1991;260:E67–74.PubMedGoogle Scholar
  34. 34.
    Fanelli C, Pampanelli S, Epifano L, Rambotti AM, Ciofetta M, Modarelli F, et al. Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans. Diabetologia. 1994;37:797–807.PubMedCrossRefGoogle Scholar
  35. 35.
    Hilsted J, Bonde-Petersen F, Norgaard MB, Greniman M, Christensen NJ, Parving HH, et al. Haemodynamic changes in insulin-induced hypoglycaemia in normal man. Diabetologia. 1984;26:328–32.PubMedCrossRefGoogle Scholar
  36. 36.
    Egeli ES, Berkmen R. Action of hypoglycemia on coronary insufficiency and mechanism of ECG alterations. Am Heart J. 1960;59:527–40.PubMedCrossRefGoogle Scholar
  37. 37.
    Galloway PJ, Thomson GA, Fisher BM, Semple CG. Insulin-induced hypoglycemia induces a rise in C-reactive protein. Diabetes Care. 2000;23:861–2.PubMedCrossRefGoogle Scholar
  38. 38.
    Razavi Nematollahi L, Kitabchi AE, Stentz FB, Wan JY, Larijani BA, Tehrani MM, et al. Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects. Metabolism. 2009;58:443–8. doi: 10.1016/j.metabol.2008.10.018.PubMedCrossRefGoogle Scholar
  39. 39.
    Del Rey A, Roggero E, Randolf A, Mahuad C, McCann S, Rettori V, et al. IL-1 resets glucose homeostasis at central levels. Proc Natl Acad Sci U S A. 2006;103:16039–44. doi: 10.1073/pnas.0607076103.PubMedCentralPubMedCrossRefGoogle Scholar
  40. 40.
    Fisher BM, Hepburn DA, Smith JG, Frier BM. Responses of peripheral blood cells to acute insulin-induced hypoglycaemia in humans: effect of alpha-adrenergic blockade. Horm Metab Res Suppl. 1992;26:109–10.PubMedGoogle Scholar
  41. 41.
    Gill GV, Woodward A, Casson IF, Weston PJ. Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes–the ‘dead in bed’ syndrome revisited. Diabetologia. 2009;52:42–5. doi: 10.1007/s00125-008-1177-7.PubMedCrossRefGoogle Scholar
  42. 42.
    Laitinen T, Lyyra-Laitinen T, Huopio H, Vauhkonen I, Halonen T, Hartikainen J, et al. Electrocardiographic alterations during hyperinsulinemic hypoglycemia in healthy subjects. Ann Noninvasive Electrocardiol. 2008;13:97–105. doi: 10.1111/j.1542-474X.2008.00208.x.PubMedCrossRefGoogle Scholar
  43. 43.
    Robinson RT, Harris ND, Ireland RH, Lee S, Newman C, Heller SR. Mechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia. Diabetes. 2003;52:1469–74.PubMedCrossRefGoogle Scholar
  44. 44.
    Koivikko ML, Karsikas M, Salmela PI, Tapanainen JS, Ruokonen A, Seppanen T, et al. Effects of controlled hypoglycaemia on cardiac repolarisation in patients with type 1 diabetes. Diabetologia. 2008;51:426–35. doi: 10.1007/s00125-007-0902-y.PubMedCrossRefGoogle Scholar
  45. 45.
    Umpierrez GE, Smiley D, Zisman A, Prieto LM, Palacio A, Ceron M, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care. 2007;30:2181–6. doi: 10.2337/dc07-0295.PubMedCrossRefGoogle Scholar
  46. 46.
    Maynard G, Lee J, Phillips G, Fink E, Renvall M. Improved inpatient use of basal insulin, reduced hypoglycemia, and improved glycemic control: effect of structured subcutaneous insulin orders and an insulin management algorithm. J Hosp Med. 2009;4:3–15. doi: 10.1002/jhm.391.PubMedCrossRefGoogle Scholar
  47. 47.
    Korytkowski M, Dinardo M, Donihi AC, Bigi L, Devita M. Evolution of a diabetes inpatient safety committee. Endocr Pract. 2006;12 Suppl 3:91–9.PubMedCrossRefGoogle Scholar
  48. 48.
    Schnipper JL, Magee M, Larsen K, Inzucchi SE, Maynard G, Society of Hospital Medicine Glycemic Control Task Force. Society of Hospital Medicine Glycemic Control Task Force summary: practical recommendations for assessing the impact of glycemic control efforts. J Hosp Med. 2008;3:66–75. doi: 10.1002/jhm.356.PubMedCrossRefGoogle Scholar
  49. 49.
    Bode BW, Braithwaite SS, Steed RD, Davidson PC. Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy. Endocr Pract. 2004;10 Suppl 2:71–80.PubMedCrossRefGoogle Scholar
  50. 50.
    Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates DW. The incidence and severity of adverse events affecting patients after discharge from the hospital. Ann Intern Med. 2003;138:161–7.PubMedCrossRefGoogle Scholar
  51. 51.
    Shorr RI, Ray WA, Daugherty JR, Griffin MR. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med. 1997;157:1681–6.PubMedCrossRefGoogle Scholar
  52. 52.
    Clement S, Braithwaite SS, Magee MF, Ahmann A, Smith EP, Schafer RG, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27:553–91.PubMedCrossRefGoogle Scholar
  53. 53.
    Lauster CD, Gibson JM, DiNella JV, DiNardo M, Korytkowski MT, Donihi AC. Implementation of standardized instructions for insulin at hospital discharge. J Hosp Med. 2009;4:E41–2. doi: 10.1002/jhm.489.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York (outside the USA) 2013

Authors and Affiliations

  • Leslie Eiland
    • 1
    • 2
  • Whitney Goldner
    • 2
  • Andjela Drincic
    • 2
  • Cyrus Desouza
    • 1
    • 2
    Email author
  1. 1.VA Nebraska – Western Iowa Health Care SystemOmahaUSA
  2. 2.Department of Internal Medicine, Division of Diabetes, Endocrinology and MetabolismUniversity of Nebraska Medical CenterOmahaUSA

Personalised recommendations